According to the planning, the implementation of the National Vaccination Plan against it continues COVID-19 with all the available licensed vaccines, following the re-formulation today by the European Medicines Agency (Coreper) of the position that the vaccination of citizens should continue smoothly and at a fast pace.
After a thorough examination of the data and the possible association of the AstraZeneca vaccine with cases of thrombosis, the competent body expressed the scientific position that the vaccine remains effective and safe and that the benefits of its administration outweigh the risks of side effects. According to the European Medicines Agency, states can continue to administer this vaccine, without limits. Coreper concludes that the possibility of thrombosis occurs after vaccination are extremely rare, however will be included in the side effects in the Package Leaflet for information purposes only.
It is reminded that until tomorrow, April 8, at 7 pm, priority for arranging appointments is given to people aged 61 and over. Citizens belonging to this age group are encouraged to schedule their appointment as soon as possible, since any delay carries an increased risk of serious illness in case of contamination.